-Hideo Yoshida Researcher Activity Profile

Research Author Detailed Information 

Hideo Yoshida Publication Rate By Year

Hideo Yoshida has published 1 paper(s) in 2006, 7 paper(s) in 2007, 2 paper(s) in 2008, for a total of 10 research publications in total.

Hideo H Yoshida Author Information

LAST NAME: yoshida

FIRST NAME: hideo

INITIALS: H

AFFILIATION:

Papers

Hideo Yoshida's Publication Record

1. Induction therapy with twice-daily interferon-beta does not improve the therapeutic efficacy of consensus interferon monotherapy for chronic hepatitis C. Year Published: 2006
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan. hsaito@sc.itc.keio.ac.jp
2. Autoantibodies to RNA helicase A: a new serologic marker of early lupus. Year Published: 2007
University of Florida, Gainesville, FL 32610, USA.
3. Investigation of optimal schedule of concurrent radiotherapy with S-1 for oral squamous cell carcinoma. Year Published: 2007
Department of Therapeutic Regulation for Oral Tumors, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima 770-8504, Japan. harako@dent.tokushima-u.ac.jp.
4. Randomized trial of steroid-free induction versus corticosteroid maintenance among orthotopic liver transplant recipients with hepatitis C virus: impact on hepatic fibrosis progression at one year. Year Published: 2007
Department of Surgery, University of Miami School of Medicine, Miami, FL, USA. tkato@med.miami.edu
5. Recurrent hepatocellular carcinoma has an increased risk of subsequent recurrence after curative treatment. Year Published: 2007
Department of Gastroenterology, University of Tokyo, Graduate School of Medicine, Tokyo, Japan.
6. Investigation of optimal schedule of concurrent radiotherapy with S-1 for oral squamous cell carcinoma. Year Published: 2007
Department of Therapeutic Regulation for Oral Tumors, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima 770-8504, Japan. harako@dent.tokushima-u.ac.jp.
7. Recurrent hepatocellular carcinoma has an increased risk of subsequent recurrence after curative treatment. Year Published: 2007
Department of Gastroenterology, University of Tokyo, Graduate School of Medicine, Tokyo, Japan.
8. Endoscopic sphincterotomy is a useful preoperative management for refractory pancreatitis associated with pancreaticobiliary maljunction. Year Published: 2008
Department of Pediatric Surgery, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan. kta@cc.rim.or.jp
9. Recurrent hepatocellular carcinoma has an increased risk of subsequent recurrence after curative treatment. Year Published: 2007
Department of Gastroenterology, University of Tokyo, Graduate School of Medicine, Tokyo, Japan.
10. Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients. Year Published: 2008
Department of Gastroenterology, University of Tokyo, Hongo, Tokyo, Japan.